Norma E. Fox

2.2k total citations
33 papers, 1.9k citations indexed

About

Norma E. Fox is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Norma E. Fox has authored 33 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 10 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Norma E. Fox's work include Platelet Disorders and Treatments (16 papers), Lipid metabolism and disorders (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Norma E. Fox is often cited by papers focused on Platelet Disorders and Treatments (16 papers), Lipid metabolism and disorders (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Norma E. Fox collaborates with scholars based in United States, United Kingdom and Japan. Norma E. Fox's co-authors include Kenneth Kaushansky, Amy E. Geddis, Keita Kirito, Thalia Papayannopoulou, Peter R. Twentyman, Jonathan G. Drachman, Diana F. Sabath, P R Twentyman, J. K. H. Rees and N M Bleehen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Norma E. Fox

33 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norma E. Fox United States 24 1.0k 726 510 431 281 33 1.9k
Keita Kirito Japan 29 1.1k 1.0× 1.2k 1.6× 585 1.1× 433 1.0× 375 1.3× 128 2.3k
Yotis A. Senis United Kingdom 28 1.2k 1.1× 776 1.1× 217 0.4× 249 0.6× 552 2.0× 65 2.2k
Pascale Cornillet‐Lefèbvre France 23 931 0.9× 793 1.1× 328 0.6× 313 0.7× 305 1.1× 49 2.0k
Véronique Mansat‐De Mas France 25 1.4k 1.4× 1.3k 1.7× 546 1.1× 428 1.0× 358 1.3× 57 2.5k
O. Müller France 17 473 0.5× 741 1.0× 254 0.5× 713 1.7× 378 1.3× 22 1.7k
Jérôme Tamburini France 31 1.3k 1.2× 2.2k 3.0× 535 1.0× 540 1.3× 359 1.3× 88 3.3k
Gautam Shrikhande United States 24 363 0.4× 787 1.1× 186 0.4× 197 0.5× 392 1.4× 42 1.8k
Aaron J. Donner United States 15 655 0.6× 1.1k 1.6× 250 0.5× 354 0.8× 213 0.8× 18 2.1k
Florian H. Heidel Germany 30 1.8k 1.7× 1.7k 2.3× 995 2.0× 509 1.2× 312 1.1× 143 3.1k

Countries citing papers authored by Norma E. Fox

Since Specialization
Citations

This map shows the geographic impact of Norma E. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norma E. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norma E. Fox more than expected).

Fields of papers citing papers by Norma E. Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norma E. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norma E. Fox. The network helps show where Norma E. Fox may publish in the future.

Co-authorship network of co-authors of Norma E. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Norma E. Fox. A scholar is included among the top collaborators of Norma E. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norma E. Fox. Norma E. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yunyuan V., Mathias Leblanc, Norma E. Fox, et al.. (2011). Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity. Genes & Development. 25(13). 1426–1438. 44 indexed citations
4.
Nakao, Takafumi, Amy E. Geddis, Norma E. Fox, & Kenneth Kaushansky. (2008). PI3K/Akt/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27Kip1. Cell Cycle. 7(2). 257–266. 61 indexed citations
5.
Geddis, Amy E., Norma E. Fox, Eugene Tkachenko, & Kenneth Kaushansky. (2007). Endomitotic Megakaryocytes that Form a Bipolar Spindle Exhibit Cleavage Furrow Ingression Followed by Furrow Regression. Cell Cycle. 6(4). 455–460. 58 indexed citations
6.
Coleman, Thomas R., Christof Westenfelder, Florian Tögel, et al.. (2006). Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proceedings of the National Academy of Sciences. 103(15). 5965–5970. 101 indexed citations
7.
Geddis, Amy E., Norma E. Fox, & Kenneth Kaushansky. (2006). The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels. Experimental Hematology. 34(1). 82–86. 19 indexed citations
8.
Fox, Norma E. & Kenneth Kaushansky. (2005). Engagement of integrin α4β1 enhances thrombopoietin-induced megakaryopoiesis. Experimental Hematology. 33(1). 94–99. 35 indexed citations
10.
Nakao, Takafumi, Amy E. Geddis, Norma E. Fox, & Kenneth Kaushansky. (2005). PI3K/Akt/FOXO3a Pathway Contributes to Thrombopoietin-Induced Proliferation of Primary Megakaryocytes In Vitro and In Vivo Via Modulation of p27Kip1.. Blood. 106(11). 202–202. 13 indexed citations
11.
Fox, Norma E., et al.. (2002). Thrombopoietin expands hematopoietic stem cells after transplantation. Journal of Clinical Investigation. 110(3). 389–394. 129 indexed citations
12.
Fox, Norma E., et al.. (2002). Thrombopoietin expands hematopoietic stem cells after transplantation. Journal of Clinical Investigation. 110(3). 389–394. 136 indexed citations
13.
Geddis, Amy E., Norma E. Fox, & Kenneth Kaushansky. (2001). Phosphatidylinositol 3-Kinase Is Necessary but Not Sufficient for Thrombopoietin-induced Proliferation in Engineered Mpl-bearing Cell Lines as Well as in Primary Megakaryocytic Progenitors. Journal of Biological Chemistry. 276(37). 34473–34479. 67 indexed citations
14.
Rojnuckarin, Ponlapat, et al.. (2001). The Roles of Phosphatidylinositol 3-Kinase and Protein Kinase Cζ for Thrombopoietin-induced Mitogen-activated Protein Kinase Activation in Primary Murine Megakaryocytes. Journal of Biological Chemistry. 276(44). 41014–41022. 28 indexed citations
15.
Carow, C, Norma E. Fox, & Kenneth Kaushansky. (2001). Kinetics of endomitosis in primary murine megakaryocytes. Journal of Cellular Physiology. 188(3). 291–303. 28 indexed citations
16.
Twentyman, P R, K A Wright, & Norma E. Fox. (1990). Characterisation of a mouse tumour cell line with in vitro derived resistance to verapamil. British Journal of Cancer. 61(2). 279–284. 11 indexed citations
17.
Twentyman, Peter R., Norma E. Fox, & J. K. H. Rees. (1989). Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay. British Journal of Haematology. 71(1). 19–24. 116 indexed citations
18.
Twentyman, P R, Norma E. Fox, K A Wright, & N M Bleehen. (1986). Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells. British Journal of Cancer. 53(4). 529–537. 104 indexed citations
19.
Twentyman, P R, Norma E. Fox, K A Wright, et al.. (1986). The in vitro effects and cross-resistance patterns of some novel anthracyclines. British Journal of Cancer. 53(5). 585–594. 31 indexed citations
20.
Twentyman, P R, Norma E. Fox, Paul Workman, et al.. (1985). Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma). British Journal of Cancer. 52(4). 495–504. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026